Tuesday, 28 January 2020

Generics News

  • “Chinese generics market has no strategy for international players”

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 17 Nov, 2014

    Singapore: In the last one year, Actavis has been aggressive in expanding its presence in Asia and the company was on an acquisition spree. Marking a direct presence in Asia, Actavis launch...Read more

  • US FDA imposes import alert on Ranbaxy drugs

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: The US FDA has issued an alert on import of Ranbaxy Laboratories drug products that are manufactured at its plant in Mohali, India. The firm will remain on the import alert unt...Read more

  • Apollo Pharmacy cautions against Ranbaxy drugs' use

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    New Delhi: Spelling further problems for India's pharma giant Ranbaxy and its Japanese owners Daiichi Sankyo, Apollo Pharmacy has issued a 'cautionary advisory' against the use of all drugs...Read more

  • Asian generic companies focus more on market expansion

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2015

    Singapore: A Frost & Sullivan (F&S) analysis finds that the Asian generic market is expected to grow at a compound annual growth rate of 17-18 percent between 2014 and 2018. The tea...Read more

  • Taiwan's TWi to independently hit the US market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2015

    Singapore: Taiwan-based TWi Pharmaceuticals has decided to sell its products in the US market through its own US subsidiary, instead of the original plan of selling through Teva Pharmaceuti...Read more

  • Comply or face action: US FDA tells Indian drugmakers

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: With increasing number of non-compliance issues being logged against Indian drugmakers by the US FDA, this time the American regulatory body has instructed the companies to eithe...Read more

  • Dr. Reddy's launches generic Finasteride

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

    Hyderabad: Dr. Reddy's Laboratories has launched Finasteride tablets (1 mg), a bioequivalent generic version of Propecia (Finasteride) in the US market on January 02, 2013. Dr. Reddy's A...Read more

  • Suzhou Amerigen launches Mecobalamin in China

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2014

    Singapore: US-based Amerigen Pharmaceuticals' Chinese subsidiary, Suzhou Amerigen Pharmaceuticals has received Chinese FDA (CFDA) approval for its generic Mecobalamin 0.5 mg tablets. The co...Read more

  • ANI pharma acquires 22 generic drug from Teva

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2015

    Singapore: US based ANI Pharmaceuticals has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for USD25 million in cash and a percentage of future gross profit...Read more

  • Patents rights in India unreasonably denied: US Pharma

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2013

    Singapore: Expressing grave concern over the deteriorating intellectual property environment in India, the Pharmaceutical Research and Manufacturers of America (PhRMA) have said that the si...Read more

  • Sun Pharma cancer drug to address shortage

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: The US Food and Drug Administration has approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) made by Indian generics drug ma...Read more

  • Prasco Lab to market generics version of Colcrys in US

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2015

    Singapore: US generics firm, Prasco Laboratories, has entered into alliance with US subisdiary of Japanese pharmaceutical compamy, Takeda, to distribute Colchicine tablets, the generic vers...Read more

  • Jubilant smoking cessation aid gets FDA nod

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Oct, 2013

    Singapore: India's leading pharma company, Jubilant Life Sciences received an approval from the US FDA for its anti-depressant drug, Bupropion Hydrochloride. The company said in a statemen...Read more

  • Aussie's IDT to manufacture 23 generic drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Apr, 2015

    Singapore: US FDA has accepted the transfer of ownership of 23 generic drug products to Australia based IDT. Formalising change of ownership is a process whereby the vendor and the purchase...Read more

  • Novartis case hearing against Indian patent office on Sept 11

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

    Bangalore: The Supreme Court will take up the landmark case involving swiss drugmaker Novartis and India's patent office on September 11, 2011. The case was due to come up for hearing on Au...Read more

  • Generics will lead to $7 bn loss for statins market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

    Singapore: GBI Research has highlighted that the introduction of generic statins has kick started a decline in the global statins market and this is expected to lead to a loss of over $7 bi...Read more

  • Sun Pharma's founder named India's 3rd richest

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Oct, 2013

    Singapore: For the first time, founder of leading Indian drugmaker Sun Pharmaceuticals, Mr Dilip Shanghvi has been named in the top three of India's richest men. Mr Shanghvi has made an ap...Read more

  • Mylan launches generic of Pfizer's antifungal drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: US-based Mylan Pharmaceuticals has launched generic version of Pfizer's Vfend, Voriconazole for Oral Suspension, 40 mg/mL. Mylan was the first company to have filed a substantia...Read more



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls